Corien Eeltink
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Family Practice top 5%
Papers in
- Oncology 19
- Cancer survivorship and care 13
- Cancer Treatment and Pharmacology 5
- Hematology 11
- Acute Myeloid Leukemia Research 8
- Co-authors
- Jan Baptist Vermorken (7 shared papers)Irma M. Verdonck‐de Leeuw (13 shared papers)Gert Jan Ossenkoppele (8 shared papers)Arjan A. van de Loosdrecht (8 shared papers)Theresia M. Westers (6 shared papers)Otto J. Visser (6 shared papers)Wim J.F. van der Vijgh (4 shared papers)Peter C. Huijgens (5 shared papers)
- Journals
- Bone Marrow Transplantation (5 papers)Blood (4 papers)Supportive Care in Cancer (4 papers)European Journal of Cancer (3 papers)BMC Cancer (2 papers)
- Partner nations
- NetherlandsItalyUnited Kingdom
In The Last Decade
Corien Eeltink
48 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Hematology 292
- Family Practice 39
- Oncology 314
- Genetics 49
- General Health Professions 94
Countries citing papers authored by Corien Eeltink
This map shows the geographic impact of Corien Eeltink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corien Eeltink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corien Eeltink more than expected).
Fields of papers citing papers by Corien Eeltink
This network shows the impact of papers produced by Corien Eeltink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corien Eeltink. The network helps show where Corien Eeltink may publish in the future.
Co-authors
The 25 scholars most cited alongside Corien Eeltink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 112 | |
| 2 | 2009 | 79 | |
| 3 | A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors. | 1997 | 76 |
| 4 | 2018 | 76 | |
| 5 | 2009 | 59 | |
| 6 | 2015 | 53 | |
| 7 | 2017 | 53 | |
| 8 | 2014 | 45 | |
| 9 | 1997 | 44 | |
| 10 | 2018 | 39 | |
| 11 | 2015 | 38 | |
| 12 | 2017 | 37 | |
| 13 | 1993 | 33 | |
| 14 | 2014 | 32 | |
| 15 | 2014 | 30 | |
| 16 | 2010 | 22 | |
| 17 | 2022 | 22 | |
| 18 | 2013 | 20 | |
| 19 | 2010 | 18 | |
| 20 | 2017 | 18 |
About Corien Eeltink
Corien Eeltink is a scholar working on Oncology, Hematology, Psychiatry and Mental health, General Health Professions and Public Health, Environmental and Occupational Health, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer survivorship and care (13 papers), Acute Myeloid Leukemia Research (8 papers), Sexual function and dysfunction studies (8 papers), Palliative and Oncologic Care (6 papers), Cancer Treatment and Pharmacology (5 papers), Patient-Provider Communication in Healthcare (4 papers), Palliative Care and End-of-Life Issues (4 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). The work is most often cited by research in Hematology (292 citations), Family Practice (39 citations), Oncology (314 citations), Genetics (49 citations) and General Health Professions (94 citations). Corien Eeltink has collaborated with scholars based in Netherlands, Italy and United Kingdom. Frequent co-authors include Jan Baptist Vermorken, Irma M. Verdonck‐de Leeuw, Gert Jan Ossenkoppele, Arjan A. van de Loosdrecht, Theresia M. Westers, Otto J. Visser, Wim J.F. van der Vijgh, Peter C. Huijgens, Martine E.D. Chamuleau and Canan Alhan. Their work appears in journals such as Bone Marrow Transplantation, Blood, Supportive Care in Cancer, European Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.